Shareholding

Share capital

Total number of shares and voting rights comprising Exosens' Share Capital

(article L.233-8-II of the French Commercial Code and article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

DateTotal number of issued shares Total number of voting rights
January 14, 202550 782 552

Number of theoretical voting rights: 50,782,552

 

Number of exercisable voting rights*: 50,769,155

* After deduction of any treasury shares without voting rights

Shareholders

Shareholders

Number of shares

% of share capital

Number of voting rights

% of voting rights

HLD (*)

23 278 438

45.84%

23 278 438

45.85%

Bpifrance Participations

2 285 260

4.50%

2 285 260

4.50%

Minority shareholders

3 879 111

7.64%

3 879 111

7.64%

Treasury shares

13 397

0.03%

-

-

Free float

21 326 346

42.00%

21 326 346

42.01%

Total

50 782 552 

100%

50 769 155

100%

(*) includes HLD Europe, Invest Prince Henri and Invest Gamma

Analysts

The following list of analysts is for informational purposes only and does not constitute an endorsement by Exosens of any of the securities analysts or brokerage firms listed. Exosens does not guarantee the completeness of this list, which is subject to change.

In addition, any opinions, estimates or forecasts regarding Exosens' performance made by these analysts are not opinions, estimates or forecasts of Exosens or its management. Exosens does not represent or endorse the accuracy of these analysts' information, conclusions or recommendations.

 

FirmAnalyst
Kepler ChevreuxAymeric Poulain 
Kepler ChevreuxHugo Paternoster
BNP ParibasLaurent Gelebart
BNP ParibasTristan Sanson
OddoAurélien Sivignon 
OddoYan Derocles
JP MorganDavid H Perry
Bernstein SGAleksander Peterc
CitibankCharles J Armitage